Skip to main content
SpringerLink
Log in

Transport and Metabolism of the Tea Flavonoid (–)-Epicatechin by the Human Intestinal Cell Line Caco-2

  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

Purpose: Tea flavonoids, including (–)-epicatechin (EC), have been suggested to have chemopreventive properties in cancer. However, there is limited knowledge of the oral bioavailability of these dietary compounds. The purpose of this study was to gain a better understanding of the absorption of EC.

Methods: The intestinal epithelial membrane transport of EC was examined using the monolayer of the human Caco-2 cell line grown in Transwells, a common model of intestinal absorption. EC and its metabolites were measured by high performance liquid chromatography with diode array detection.

Results: EC showed no apical to basolateral absorption at concentrations ranging from 5 to 50 μM. In contrast, EC demonstrated basolateral to apical efflux with a P app value of 0.67 ± 0.05 × 10−6 cm/sec, i.e., slightly higher than for mannitol, 0.50 ± 0.30 × 10−6 cm/sec, a paracellular transport marker. There was a 50% reduction in the efflux of EC in the presence of 50 μM MK-571, a competitive inhibitor of the MRP2 transporter expressed in the apical membrane of Caco-2 cells. Most important, the presence of 50 μM MK-571 resulted in clearly measurable apical to basolateral absorption of EC with a P app of 0.31 ± 0.06 × 10−6 cm/sec. Two polar metabolites, M1 and M2, were formed from EC, both of which appeared exclusively on the apical side. MK-571 (50 μM) dramatically inhibited the transport for both of these metabolites. Incubations with inorganic 35SO4 2− and hydrolysis by aryl sulfatase strongly suggested that these metabolites were sulfate conjugates.

Conclusions: These results suggest an important role for the multispecific organic anion transporter MRP2 in the bioavailability of EC and possibly other tea flavonoids.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

REFERENCES

  1. M. G. L. Hertog, P. C. H. Hollman, and M. B. Katan. Content of potentially anticarcinogenic flavonoids of 28 vegetables and 9 fruits commonly consumed in the Netherlands. J. Agric. Food Chem. 40:2379-2383 (1992).

    Google Scholar 

  2. M. G. L. Hertog, P. C. H. Hollman, and B. van de Putte. Content of potentially anticarcinogenic flavonoids of tea infusions, wines and fruit juices. J. Agric. Food Chem. 41:1242-1246 (1993).

    Google Scholar 

  3. I. C. Arts, B. van De Putte, and P. C. Hollman. Catechin contents of foods commonly consumed in the Netherlands. 2. Tea, wine, fruit juices, and chocolate milk. J. Agric. Food Chem. 48:1752-7. (2000).

    Google Scholar 

  4. C. S. Yang and Z. Y. Wang. Tea and cancer. J. Natl. Cancer Inst. 85:1038-49. (1993).

    Google Scholar 

  5. R. W. Teel and H. Huynh. Effect of phytochemicals on CYP 450 linked alkoxyresorufin O-dealkylase activity. Phyto. Res. 12:89-93 (1998).

    Google Scholar 

  6. S. K. Katiyar and H. Mukhtar. Tea in chemoprevention of cancer. Int. J. Oncol. 7:133-141 (1996).

    Google Scholar 

  7. Y. L. Lin and J. K. Lin. (−)-Epigallocatechin-3-gallate blocks the induction of nitric oxide synthase by down-regulating lipopolysaccharide-induced activity of transcription factor nuclear factor-kappaB. Mol. Pharmacol. 52:465-472. (1997).

    Google Scholar 

  8. Z. Dong, W. Ma, C. Huang, and C. S. Yang. Inhibition of tumor promoter-induced activator protein 1 activation and cell transformation by tea polyphenols, (−)-epigallocatechin gallate, and theaflavins. Cancer Res. 57:4414-4419. (1997).

    Google Scholar 

  9. M. J. Lee, Z. Y. Wang, H. Li, L. Chen, Y. Sun, S. Gobbo, D. A. Balentine, and C. S. Yang. Analysis of plasma and urinary tea polyphenols in human subjects. Cancer Epidemiol. Biomarkers Prev. 4:393-399. (1995).

    Google Scholar 

  10. C. S. Yang, L. Chen, M. J. Lee, D. A. Balentine, M. C. Kuo, and S. P. Schantz. Blood and urine level of tea catechin after ingestion of different amounts of green tea by human volunteers. Cancer Epidemiol. Biomarkers Prev. 7:351-354 (1998).

    Google Scholar 

  11. S. Baba, N. Osakabe, A. Yasuda, M. Natsume, T. Takizawa, T. Nakamura, and J. Terao. Bioavailability of (−)-epicatechin upon intake of chocolate and cocoa in human volunteers. Free Rad. Res. 33:635-641 (2000).

    Google Scholar 

  12. H. H. S. Chow, Y. Cai, D. S. Alberts, I. Hakim, R. Dorr, F. Shahi, J. A. Crowell, C. S. Yang, and Y. Hara. Phase I pharmacokinetic study of tea polyphenols following single-dose administration of epigallocatechin gallate and polyphenon E. Cancer Epidemiol. Biomark. Prev. 10:53-58 (2001).

    Google Scholar 

  13. H. Lennernas. Human jejunal effective permeability and its correlation with preclinical drug absorption models. J. Pharm. Pharmacol. 49:627-38 (1997).

    Google Scholar 

  14. P. Artursson. Epithelial transport of drugs in cell culture. I: A model for studying the passive diffusion of drugs over intestinal absorptive (Caco-2) cells. J. Pharm. Sci. 79:476-482 (1990).

    Google Scholar 

  15. S. Yee. In vivo permeability across Caco-2 cells can predict in vivo (small absorption) in man-fact or myth. Pharm. Res. 14:763-766 (1997).

    Google Scholar 

  16. P. Artursson and J. Karlsson. Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. Biochem. Biophys. Res. Commun. 175:880-885 (1991).

    Google Scholar 

  17. R. A. Walgren, U. K. Walle, and T. Walle. Transport of quercetin and its glucosides across human intestinal epithelial Caco-2 cells. Biochem. Pharmacol. 55:1721-1727 (1998).

    Google Scholar 

  18. U. K. Walle, A. Galijatovic, and T. Walle. Transport of the flavonoid chrysin and its conjugated metabolites by the human intestinal cell line Caco-2. Biochem. Pharmacol. 58:431-438 (1999).

    Google Scholar 

  19. I. Leier, G. Jedlitschky, U. Buchholz, S. P. C. Cole, R. G. Deeley, and D. Keppler. The MRP gene encodes an ATP-dependent export pump for leukotriene C4 and structurally related conjugates. J. Biol. Chem. 269:27807-27810 (1994).

    Google Scholar 

  20. G. Jedlitschky, I. Leier, and U. Buchholz. ATP-dependent tranport of glutathine S-conjugates by the multidrug resistance-associated protein. Cancer Res. 54:4833-4836 (1994).

    Google Scholar 

  21. T. Tsuruo, H. Iida, S. Tsukagoshi, and Y. Sakurai. Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil. Cancer Res. 41:1967-1972 (1981).

    Google Scholar 

  22. F. J. Sharom. The P-glycoprotein efflux pump: How does it trasport drugs? J. Membr. Biol. 160:161-175 (1997).

    Google Scholar 

  23. Q. Y. Zhu, A. Zhang, D. Tsang, Y. Huang, and Z. Chen. Stability of green tea catechins. J. Agric. Food Chem. 45:4624-4628 (1997).

    Google Scholar 

  24. A. Galijatovic, Y. Otake, U. K. Walle, and T. Walle. Extensive metabolism of the flavonoid chrysin by human Caco-2 and Hep G2 cells. Xenobiotica 29:1241-1256 (1999).

    Google Scholar 

  25. T. Walle, U. K. Walle, K. R. Thornburg, and K. L. Schey. Stereoselective sulfation of albuterol in humans: biosynthesis of the sulfate conjugate by Hep G2 cells. Drug Metab. Dispos. 21:76-80 (1993).

    Google Scholar 

  26. J. Hunter, M. A. Jepson, T. Tsuruo, N. L. Simmons, and B. H. Hirst. Functional expression of P-glycoprotein in apical membranes of human intestinal Caco-2 cells — kinetics of vinblastine secretion and interaction with modulators. J. Biol. Chem. 268:14991-14997 (1993).

    Google Scholar 

  27. U. K. Walle and T. Walle. Taxol transport by human intestinal epithelial Caco-2 cells. Drug Metab. Dispos. 26:343-346 (1998).

    Google Scholar 

  28. R. A. Walgren, K. J. Karnaky, Jr., G. E. Lindenmayer, and T. Walle. Efflux of dietary flavonoid quercetin 4′-β-glucoside across human intestinal Caco-2 cell monolayers by apical multidrug resistance-associated protein-2. J. Pharmacol. Exp. Ther. 294:830-836 (2000).

    Google Scholar 

  29. D. W. Loe, R. G. Deeley, and S. P. C. Cole. Characterization of vincristine transport by the Mr 190,000 multidrug resistance protein (MRP): Evidence for cotransport with reduced glutathione. Cancer Res. 58:5130-5136 (1998).

    Google Scholar 

  30. K. Okushio, M. Suzuki, N. Matsumoto, F. Nanjo, and Y. Hara. Identification of (−)-epicatechin metabolites and their metabolic fate in the rat. Drug Metab. Dispos. 27:309-316 (1999).

    Google Scholar 

  31. J. König, A. T. Nies, Y. Cui, I. Leier, and D. Keppler. Conjugate export pumps of the multidrug resistance protein (MRP) family: localization, substrate specificity, and MRP2-mediated drug resistance. Biochim. Biophys. Acta 1461:377-394 (1999).

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Cell and Molecular Pharmacology and Experimental Therapeutics, Medical University of South Carolina, 173 Ashley Avenue, P.O. Box 250505, Charleston, South Carolina, 29425

    Jaya Bharathi Vaidyanathan & Thomas Walle

Authors
  1. Jaya Bharathi Vaidyanathan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Thomas Walle
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vaidyanathan, J.B., Walle, T. Transport and Metabolism of the Tea Flavonoid (–)-Epicatechin by the Human Intestinal Cell Line Caco-2. Pharm Res 18, 1420–1425 (2001). https://doi.org/10.1023/A:1012200805593

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1012200805593

Search

Navigation